Needham & Company Upgrades Progenics Pharmaceuticals (PGNX) to Buy on Positive PSMA Data at ASCO-GU

Go back to Needham & Company Upgrades Progenics Pharmaceuticals (PGNX) to Buy on Positive PSMA Data at ASCO-GU
Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) Delayed: 4.10 --0 (-0%)
Previous Close $4.10    52 Week High $7.75 
Open $4.10    52 Week Low $3.61 
Day High $4.10    P/E N/A 
Day Low $4.10    EPS $-0.62 
Volume 1,467